PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026ACS Medicinal Chemistry Letters0 citations

Misconceptions in Unbound Volume of Distribution and Their Implications for Pharmacokinetic Scaling and Drug Design

View Full Paper
HZHongtao Zhao

Key Points

  • To explore the misconceptions surrounding unbound volume of distribution and its implications for pharmacokinetic scaling and drug design.
  • Conducted mechanistic analysis of factors influencing unbound volume of distribution.
  • Examined the role of plasma protein binding in modulating drug properties.
  • Analyzed evidence from various rat strains to assess variability.
  • Plasma protein binding significantly affects drug half-life and hepatic extraction.
  • Findings indicate that unbound volume of distribution is not an invariant property across species.
  • Results highlight the need to consider plasma protein binding in drug design and scaling.

Abstract

Unbound volume of distribution is often treated as an intrinsic, species-invariant property. However, mechanistic analysis demonstrates that it is influenced by plasma protein binding, particularly when plasma and tissue binding are coupled through shared binding components and their relative compartmental distribution. Evidence across rat strains suggests that plasma protein binding significantly modulates half-life and hepatic extraction, thereby impacting in vivo efficacy. These insights argue for revisiting common cross-species scaling practices and for considering plasma protein binding as an explicit design parameter.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hongtao Zhao (2026) studied this question.

synapsesocial.com/papers/69994b01873532290d01f4f2https://doi.org/10.1021/acsmedchemlett.6c00063
Ask AI
Helpful
Bookmark
Share
View Full Paper